Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | CCR2 | P41597 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.31 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5401924 | 1.00 | THRB (0.36) | THRBTDP1CYP3A4TP53ALOX15 | |
| SCHEMBL5401929 | 1.00 | THRB (0.36) | THRBTDP1CYP3A4TP53ALOX15 | |
| SCHEMBL29870908 | 0.86 | RXRA (0.39) | THRBTDP1CYP3A4TP53ALOX15 | |
| SCHEMBL1468020 | 0.86 | RXRA (0.39) | THRBTDP1CYP3A4TP53ALOX15 | |
| SCHEMBL9716941 | 0.82 | KMT2A (0.35) | KMT2AMEN1MAPTHTTCCR2 | |
| SCHEMBL29871012 | 0.80 | CCR2 (0.39) | THRBTDP1CYP2A6KMT2AMEN1 | |
| SCHEMBL3987004 | 0.80 | CCR2 (0.39) | THRBTDP1CYP2A6KMT2AMEN1 | |
| SCHEMBL3169625 | 0.77 | HTR2C (0.35) | THRBTDP1CYP3A4TP53ALOX15 | |
| SCHEMBL9080035 | 0.75 | RXRA (0.36) | — | |
| SCHEMBL9079442 | 0.75 | RXRA (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7253141-B2 | Musk odorant compounds | FIRMENICH SA (CH) | 2007-08-07 | — | — | US | disclosed |
| EP-1689728-B1 | MUSK ODORANT COMPOUNDS | FIRMENICH & CIE (CH) | 2007-04-11 | — | — | EP | disclosed |
| US-20060211598-A1 | Musk odorant compounds | FIRMENICH SA (CH) | 2006-09-21 | — | — | US | disclosed |
| EP-1689728-A1 | MUSK ODORANT COMPOUNDS | FIRMENICH SA (CH) | 2006-08-16 | — | — | EP | disclosed |
| WO-2005054220-A1 | MUSK ODORANT COMPOUNDS | FIRMENICH SA (CH) | 2005-06-16 | — | — | WO | disclosed |
| US-5476977-A | Perfume intermediate | FIRMENICH SA (CH) | 1995-12-19 | — | — | US | disclosed |
| EP-0552325-B1 | NOVEL NAPHTHALENE COMPOUND AND METHOD OF OBTAINING IT | FIRMENICH & CIE (CH) | 1995-04-26 | — | — | EP | disclosed |
| US-5396014-A | Process for the preparation of 4,4-dimethyl-2-pentene | FIRMENICH S.A. (CH) | 1995-03-07 | — | — | US | disclosed |
| EP-0552325-A1 | NOVEL NAPHTHALENE COMPOUND AND METHOD OF OBTAINING IT. | FIRMENICH & CIE (CH) | 1993-07-28 | — | — | EP | disclosed |
| WO-1993004023-A1 | NOVEL NAPHTHALENE COMPOUND AND METHOD OF OBTAINING IT | FIRMENICH S.A. (CH) | 1993-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211598-A1 | Musk odorant compounds | KHK, KCNK5, KLK5 | THRB 3971/4885TDP1 2924/4885CYP3A4 558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.